Clover Biopharmaceuticals
PublicClover Biopharmaceuticals is now publicly traded
The data on this page reflects Clover Biopharmaceuticals's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Follow-on Offering
Mar 27, 2026
Total Funding Raised
$3.64M
Company Overview
Clover Biopharmaceuticals operates in Biotech and is based in Shanghai, Shanghai. It has raised $3.64M.
Clover Biopharmaceuticals (HKG: 02197) is a biotechnology company focused on creating innovative vaccines and biologic therapies for infectious diseases, cancer, and autoimmune disorders.
Sector
Biotech
AI Layer
Non-AI
Clover Biopharmaceuticals Comparables
Compare Clover Biopharmaceuticals with similar companies based on industry and business-model similarity.
No comparables are published for Clover Biopharmaceuticals. Book a demo to ask about coverage.
Book a demoFor institutional investors. Book with your work email.
Clover Biopharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | Mar 27, 2026 |
For institutional investors. Book with your work email.
Clover Biopharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.